Dr. Charles A. Enke, MD

Dr. Enke practices at Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System.

Dr. Enke's NPI, 1245288455, was assigned on May 4, 2006. Dr. Enke graduated from Carver College of Medicine in 1985. Dr. Enke holds Nebraska license 17933.

Dr. Enke's primary practice is Nebraska Medical Center, at 988102 Nebrasks Medical Center, Omaha, NE 68198 in Douglas County. The practice phone is (402) 559-4000. Dr. Enke also practices at Nebraska Medical Center, 987400 Nebraska Medical Ctr, Omaha, NE 68198.

Dr. Enke's primary practice is Nebraska Medical Center in Omaha, Nebraska, part of University of Nebraska System. Dr. Enke is also affiliated with Bellevue Medical Center. The medical group on file is UNMC Physicians. Dmand AI also links Dr. Enke to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Enke practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Enke's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Enke is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Enke's licenses on file in 3 states: Nebraska, Iowa and Wisconsin.

Dmand AI lists bladder cancer radiation, bone cancer radiation, lung cancer radiation, lymphoma radiation and prostate cancer radiation among the conditions Dr. Enke treats.

CMS data shows 1,422 Medicare services from Dr. Enke across 15 procedure codes in 2024, for 240 Medicare patients. Medicare paid $99,324 for them.

CMS counts 240 Medicare patients who saw Dr. Enke in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Enke's median patient age at 75, with 8% women.

In 2024, Dr. Enke wrote 134 Medicare Part D claims for 64 patients. 97% of them were for generic drugs. CMS names the drug for 90 of them, across 2 drugs with 11 or more claims each, at $1,567 in total drug cost. In 2023, CMS named 137 claims across 2 drugs.

Dr. Enke accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Enke as offering telehealth.

Dmand AI links 42 papers to Dr. Enke, published from 2008 to 2024. 2014 was the busiest year, with 4. The most frequent topics are Prostatic Neoplasms, Radiotherapy Dosage and Radiotherapy Planning, Computer-Assisted. Dr. Enke has published most often in J Natl Compr Canc Netw. Dr. Enke's most frequent co-authors are Michael J. Baine, MD, James A. Eastham, MD and Michael Kuettel, MD.

Dmand AI links Dr. Enke to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases. NRG Oncology sponsors the most, 2.

CMS Open Payments shows 12 general payments to Dr. Enke from 7 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 64% of the total. Histosonics, Inc. paid the most, $531.

Dmand AI lists 1 award for Dr. Enke, most recently CMS Stage 1 EHR in 2013.

Dr. Enke graduated from Carver College of Medicine in 1985. Dr. Enke is a member of ASCO.

Dr. Enke is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.